- Geyser
Brands recently received a processing license and implemented
manufacturing at a licensed production (LP) facility
- The
company developed NanoFusion, an advanced nanotechnology drug-delivery
system
- GYSR
recently acquired Solace Management Group Inc.
Now that cannabis is losing its illegitimacy, derivatives of
the plant are permeating consumer markets at a rapidly growing pace, thanks to
companies such as Geyser
Brands Inc. (TSX.V: GYSR). The global cannabis-powered and science-led
consumer health care company offers products in a diverse range of markets,
from fast-moving consumer goods and over-the-counter pharmaceuticals to medical
cannabis.
In October 2018, Geyser received its Health Canada
cultivation license and, in June 2019, less than a year later, a standard
processing license. Licenses for R&D and sales are pending. In addition,
the company recently closed an acquisition that considerably increased its
brand portfolio. Driven by a management team experienced in manufacturing and
marketing, Geyser looks set to realize its vision of being a global player in
the billion-dollar cannabis and plant-powered health care markets.
Given the company’s extensive brand portfolio, the world is
Geyser’s oyster. GYSR has products in a number of global markets, including the
trillion-dollar personal and skin-care market; the $575 billion personalized
and complementary medicine market; the ballooning (CAGR 34.6 percent)
legal-marijuana market, which has been forecasted to reach $146 billion by
2025; the $4.2 trillion wellness market; and the pet care market, which is
worth around $132 billion.
Geyser recently closed on its acquisition of established
hemp-brands manufacturer Solace Management Group Inc., which added two dozen
wellness products and 57 SKUs to GYSR’s product lineup. The acquisition also
comes with a 7,500-square-foot, GMP-compliant facility belonging to an existing
innovation-hub and manufacturing subsidiary in Coquitlam, British
Columbia (http://ibn.fm/StIcV).
Solace also owns a number of brands with leading market
positions in Canada, including Apawthecary Pets, WildTails pet products,
Apothecary Naturals and Apothecary Ink, all of which currently use hemp oil in
their formulations. The brands are distributed by leading retailers across
Canada including Bosley’s and Shoppers Drug Mart. In addition, Solace recently
received approval for sales of a new pain-relief, roll-on product thanks to a
natural product number issued by Health Canada (http://ibn.fm/yXFxK).
And that’s not the only good news for Geyser. In June 2019,
Apothecary Botanicals, Geyser’s wholly owned licensed producer (LP), received a
standard processing license from Health Canada, a key development that allows
the production of a variety of products including tinctures and
supplements (http://ibn.fm/Iym76).
In addition, Geyser has developed NanoFusion, an advanced
nanotechnology drug-delivery system that transports therapeutic agents rapidly
and efficiently directly to the bloodstream for maximum absorbency. In the
past, a major challenge in producing cannabinoids for ingestion or absorption
through the skin is their insolubility.
Cannabinoids are naturally hydrophobic (afraid of water),
which makes it harder for the body to absorb them. The result is inconsistent,
unreliable dosing and onset times of up to three hours. Geyser’s NanoFusion
breaks down cannabinoid particles and combines them with naturally occurring
surfactants that lower the surface tension between cannabinoids and water,
resulting in a compound that is water compatible.
For more information, visit the company’s website at www.GeyserBrands.com
NOTE TO INVESTORS: The latest news and updates
relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment